Stay updated on Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Sign up to get notified when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.

Latest updates to the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedClinicalTrials.gov updated the displayed site revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.5.2 updated from v3.5.0.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded a Hepatocellular carcinoma topic tag and a new link to the Genetic and Rare Diseases Information Center in the Resources section. Updated the site revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check63 days agoChange DetectedRevision: v3.4.3 is now displayed, replacing the previous Revision: v3.4.2. This is a minor metadata/UI update with no impact on study information.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision: v3.4.2 has been added, while the previous funding-status notice (Revision: v3.4.1) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check98 days agoChange DetectedAdded a global site notice about a lapse in government funding and updated operation status with a link to opm.gov; the notice states the NIH Clinical Center is open. The site revision was updated from v3.4.0 to v3.4.1; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pexa-Vec and Nivolumab Combo in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pexa-Vec and Nivolumab Combo in HCC Clinical Trial page.